Total Payments
$7,636
2024 Payments
$698.73
Companies
41
Transactions
249
Medicare Patients
2,760
Medicare Billing
$168,968
Payment Breakdown by Category
Food & Beverage$7,623 (99.8%)
Education$12.27 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,623 | 247 | 99.8% |
| Education | $12.27 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,062 | 30 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $932.25 | 33 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $621.42 | 7 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $558.71 | 27 | $0 (2021) |
| Allergan, Inc. | $487.66 | 10 | $0 (2020) |
| GlaxoSmithKline, LLC. | $412.68 | 13 | $0 (2024) |
| Genentech USA, Inc. | $404.54 | 4 | $0 (2019) |
| Amgen Inc. | $307.82 | 6 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $272.06 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $268.62 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $698.73 | 17 | Amgen Inc. ($248.52) |
| 2023 | $515.22 | 24 | GlaxoSmithKline, LLC. ($144.06) |
| 2022 | $471.48 | 22 | AstraZeneca Pharmaceuticals LP ($96.62) |
| 2021 | $850.50 | 43 | AstraZeneca Pharmaceuticals LP ($119.50) |
| 2020 | $494.89 | 29 | PFIZER INC. ($152.74) |
| 2019 | $1,560 | 43 | PFIZER INC. ($353.59) |
| 2018 | $1,479 | 33 | PFIZER INC. ($320.37) |
| 2017 | $1,565 | 38 | E.R. Squibb & Sons, L.L.C. ($269.49) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $102.19 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $124.22 | General |
| Category: Bone Health | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Diabetes Care | ||||||
| 07/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Gastroenterology | ||||||
| 06/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $75.40 | General |
| Category: RESPIRATORY | ||||||
| 05/29/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Gastroenterology | ||||||
| 04/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Diabetes | ||||||
| 04/01/2024 | Medline Industries LP | — | Food and Beverage | In-kind items and services | $20.56 | General |
| 03/28/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $124.30 | General |
| Category: Bone Health | ||||||
| 02/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Gastroenterology | ||||||
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: VACCINES | ||||||
| 12/04/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Diabetes | ||||||
| 11/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Gastroenterology | ||||||
| 10/10/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Gastroenterology | ||||||
| 09/25/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: INSOMNIA | ||||||
| 08/30/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Diabetes | ||||||
| 08/22/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $85.41 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 742 | 900 | $84,418 | $40,833 |
| 2022 | 11 | 692 | 842 | $85,511 | $41,127 |
| 2021 | 7 | 624 | 828 | $91,531 | $44,571 |
| 2020 | 7 | 702 | 882 | $100,461 | $42,437 |
Total Patients
2,760
Total Services
3,452
Medicare Billing
$168,968
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 97 | 97 | $24,250 | $11,959 | 49.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 119 | $17,493 | $8,869 | 50.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 71 | 71 | $11,715 | $5,480 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 118 | $11,800 | $5,395 | 45.7% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 63 | 125 | $6,375 | $3,045 | 47.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 18 | 18 | $1,440 | $1,365 | 94.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 77 | 77 | $2,695 | $1,293 | 48.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 77 | 77 | $2,695 | $1,293 | 48.0% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 33 | 33 | $1,683 | $801.60 | 47.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $810.00 | $519.66 | 64.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 34 | 54 | $2,160 | $498.02 | 23.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 90 | 93 | $1,302 | $314.22 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 119 | 172 | $25,284 | $12,927 | 51.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 103 | 103 | $25,750 | $12,683 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 135 | $13,500 | $5,767 | 42.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 52 | 52 | $8,580 | $4,150 | 48.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 19 | 19 | $1,520 | $1,335 | 87.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 35 | 48 | $2,448 | $1,213 | 49.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 44 | 44 | $1,540 | $754.94 | 49.0% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 36 | 36 | $1,260 | $628.20 | 49.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 45 | 66 | $2,640 | $607.94 | 23.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 21 | 21 | $945.00 | $570.57 | 60.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 124 | 146 | $2,044 | $490.38 | 24.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 146 | 146 | $36,500 | $18,342 | 50.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 144 | 215 | $31,605 | $16,298 | 51.6% |
About Dr. James Smith, M.D
Dr. James Smith, M.D is a Family Medicine healthcare provider based in Milledgeville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1437209889.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Smith, M.D has received a total of $7,636 in payments from pharmaceutical and medical device companies, with $698.73 received in 2024. These payments were reported across 249 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($7,623).
As a Medicare-enrolled provider, Smith has provided services to 2,760 Medicare beneficiaries, totaling 3,452 services with total Medicare billing of $168,968. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Milledgeville, GA
- Active Since 01/10/2007
- Last Updated 07/03/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1437209889
Products in Payments
- ELIQUIS (Drug) $1,158
- FARXIGA (Drug) $664.75
- XARELTO (Drug) $403.96
- VRAYLAR (Drug) $316.98
- XIFAXAN (Drug) $272.06
- EVENITY (Biological) $263.65
- AREXVY (Drug) $263.00
- LATUDA (Drug) $223.61
- Xolair (Biological) $206.27
- NURTEC ODT (Drug) $186.23
- JARDIANCE (Drug) $172.60
- EUCRISA (Drug) $166.44
- INVOKANA (Drug) $148.73
- CHANTIX (Drug) $145.09
- LINZESS (Drug) $138.32
- MOUNJARO (Drug) $130.24
- NAMZARIC (Drug) $126.23
- SYMBICORT (Drug) $125.80
- Trulance (Drug) $125.45
- Aristada 441 mg (Drug) $124.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Milledgeville
Dr. Michael Duke, M.d, M.D
Family Medicine — Payments: $7,953
Family Medicine $7,953
Roy Deen, M.d, M.D
Family Medicine — Payments: $3,560
Family Medicine $3,560
Elizabeth Furbish, Md, MD
Family Medicine — Payments: $671.54
Family Medicine $671.54
James Kelly, M.d, M.D
Family Medicine — Payments: $119.64
Family Medicine $119.64
Dr. Charles Caulton, Md, MD
Family Medicine
Family Medicine
Dr. Ronald Boyd, Md, MD
Family Medicine
Family Medicine